Lowe Wealth Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$160 Hold
15
﹤0.01% 386
2025
Q2
$145 Hold
15
﹤0.01% 358
2025
Q1
$223 Hold
15
﹤0.01% 362
2024
Q4
$224 Hold
15
﹤0.01% 352
2024
Q3
$287 Buy
+15
New +$311 ﹤0.01% 307
2022
Q4
Sell
-4
Closed 361
2022
Q3
$0 Hold
4
﹤0.01% 351
2022
Q2
$0 Hold
4
﹤0.01% 328
2022
Q1
$0 Hold
4
﹤0.01% 334
2021
Q4
$0 Buy
+4
New +$130 ﹤0.01% 307

Other funds holding OGN

Lowe Wealth Advisors's OGN Position: Q3 2025 in Review

Lowe Wealth Advisors held its Organon & Co (OGN) position steady in Q3 2025 at 15 shares worth $160. The position accounts for ﹤0.01% of the portfolio, ranked #386.

Lowe Wealth Advisors first reported a position in OGN in Q4 2021 and has held it in 9 quarters since. The position peaked at $287 in Q3 2024. 670 funds tracked by Wall St. Rank hold OGN as of Q3 2025.

  • Lowe Wealth Advisors held 15 shares of Organon & Co worth $160 as of Q3 2025.
  • Lowe Wealth Advisors left its Organon & Co share count unchanged in Q3 2025.
  • Organon & Co made up ﹤0.01% of Lowe Wealth Advisors's portfolio in Q3 2025, its #386 holding.
  • Lowe Wealth Advisors first reported a position in Organon & Co in Q4 2021 and has held it in 9 quarters since.
  • Lowe Wealth Advisors's Organon & Co position peaked at $287 in Q3 2024.
  • 670 funds tracked by Wall St. Rank held Organon & Co as of Q3 2025.

Based on Lowe Wealth Advisors's 13F filing for Q3 2025, filed 16 Oct 2025.